FDA approves Amjevita, a biosimilar to Humira
The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.
Read MoreThe U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.
Read MoreThe U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). The new indications are for rare
Read MoreThe U.S. Food and Drug Administration today announced the 2016 Naloxone App Competition, a public contest focused on developing innovative
Read MoreThe U.S. Food and Drug Administration today announced the 2016 Naloxone App Competition, a public contest focused on developing innovative
Read MoreThe U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with
Read MoreThe U.S. Food and Drug Administration today permitted marketing of a device that uses a small balloon to treat persistent
Read MoreThe U.S. Food and Drug Administration today approved the VisuMax Femtosecond Laser for the small incision lenticule extraction (SMILE) procedure
Read MoreThe U.S. Food and Drug Administration announced today it has taken action against 55 tobacco retailers by issuing the first
Read MoreThe U.S. Food and Drug Administration today announced the awarding of a total of $21.8 million to support 42 states
Read MoreThe U.S. Food and Drug Administration today allowed marketing of two Trevo clot retrieval devices as an initial therapy for
Read MoreThe U.S. Food and Drug Administration today issued a final rule establishing that over-the-counter (OTC) consumer antiseptic wash products containing
Read MoreAfter an extensive review of the latest scientific evidence, the U.S. Food and Drug Administration announced today that it is
Read MoreThe U.S. Food and Drug Administration today approved Erelzi, (etanercept-szzs) for multiple inflammatory diseases. Erelzi is a biosimilar to Enbrel
Read MoreAs a further safety measure against the emerging Zika virus outbreak, today the U.S. Food and Drug Administration issued a
Read MoreThe U.S. Food and Drug Administration today permitted marketing of two new devices to assess a patient’s cognitive function immediately
Read MoreThe U.S. Food and Drug Administration today approved an expanded indication for the Sapien XT and Sapien 3 transcatheter heart
Read MoreThe U.S. Food and Drug Administration today issued a revised draft guidance to improve dietary supplement companies’ new dietary ingredient
Read MoreThe U.S. Food and Drug Administration announced today that the U.S. Marshals Service seized more than 100 cases of products
Read More